Credit Suisse’s VivoSim Labs VIVS Stock Holding History

Credit Suisse’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-417	Closed	-$377K	–	4518
2015 Q2	$377K	Buy	+417	New	+$467K	﹤0.01%	3895

Other funds holding VIVS

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's VIVS Position: Q3 2021 in Review

Credit Suisse sold out of VivoSim Labs (VIVS) in Q3 2021, closing a stake of 1,301 shares — an estimated $147K sold.

Credit Suisse first reported a position in VIVS in Q3 2013 and held it in 24 quarters. The position peaked at $1.18M in Q1 2014. 41 funds tracked by Wall St. Rank hold VIVS as of Q3 2021.

Credit Suisse reported no remaining VivoSim Labs position as of Q3 2021 after selling out during the quarter.
Credit Suisse sold 1,301 VivoSim Labs shares in Q3 2021, an estimated $147K.
Credit Suisse first reported a position in VivoSim Labs in Q3 2013 and held it in 24 quarters.
Credit Suisse's VivoSim Labs position peaked at $1.18M in Q1 2014.
41 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2021.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.